Most people taking Vyvanse notice weight loss within the first four weeks. In clinical trials, adults lost between 2.8 and 4.3 pounds in that initial month, depending on their dose. The effect starts early because appetite suppression kicks in within days of beginning treatment, but the measurable, consistent change shows up on the scale over those first few weeks.
What to Expect in the First Month
FDA prescribing data from controlled trials gives a clear picture of early weight loss by dose. Adults taking the lowest dose (30 mg) lost an average of 2.8 pounds in four weeks, while those on 50 mg lost 3.1 pounds, and those on the highest dose (70 mg) lost 4.3 pounds. For comparison, the placebo group actually gained about half a pound over the same period. The pattern is straightforward: higher doses produce more weight loss in the short term.
Children and teens show a similar but slightly different pattern. Adolescents aged 13 to 17 lost between 2.7 and 4.8 pounds in four weeks, while younger children (ages 6 to 12) lost between 0.9 and 2.5 pounds. These numbers reflect the medication’s side effect profile rather than an intended treatment goal, since Vyvanse is not approved or recommended as a weight loss drug.
Why Vyvanse Causes Weight Loss
Vyvanse works by increasing the activity of two chemical messengers in the brain: dopamine and norepinephrine. It both blocks these chemicals from being reabsorbed and encourages their release, which ramps up alertness and focus. But those same chemical changes also act on the brain’s appetite-regulating centers, particularly the hypothalamus. The result is a noticeably reduced desire to eat. Many people describe simply forgetting about food or feeling full much sooner than usual.
This appetite suppression is one of the most commonly reported side effects. It’s also the primary driver of weight loss on the medication. Vyvanse doesn’t significantly speed up your metabolism. It changes your relationship with hunger, which means you eat less without necessarily trying to.
Dose Matters More Than You Might Think
The clinical data shows a clear dose-dependent effect. At 30 mg, the weight loss is modest. At 70 mg, it roughly doubles. This holds true across age groups. In children aged 6 to 12, the lowest dose produced less than a pound of loss over four weeks, while the highest dose led to 2.5 pounds. In adults, the gap between 30 mg and 70 mg was about 1.5 pounds in just one month.
This doesn’t mean a higher dose is better. Dosing is based on how well the medication manages its primary condition (ADHD or binge-eating disorder), and higher doses also come with stronger side effects, including insomnia and irritability. Weight loss is a side effect, not the treatment target, and chasing a higher dose for more weight loss introduces unnecessary risk.
What Happens Beyond Four Weeks
The first month tends to show the steepest drop. After that, weight loss typically slows. Your body adapts to the medication over time, and the appetite-suppressing effect often becomes less pronounced as you settle into a stable dose. Some people continue to lose weight gradually over several months, particularly if their eating habits have shifted in a sustained way, but the rapid initial loss doesn’t continue at the same pace indefinitely.
For people prescribed Vyvanse specifically for binge-eating disorder, the weight changes are intertwined with reduced binge episodes. In those cases, the weight trajectory depends heavily on whether binge eating stays controlled, not just on appetite suppression alone.
What Happens If You Stop Taking It
Weight regain after stopping Vyvanse is a real concern. The appetite suppression disappears when the medication does, and for many people, hunger returns stronger than before. Animal research on amphetamine cessation found that subjects consumed significantly more food and gained more weight than controls for up to a month after the drug was discontinued, suggesting a rebound effect where the body overcompensates.
While human data on this specific rebound is limited, the clinical pattern is well recognized. People who relied on Vyvanse’s appetite suppression without building independent eating habits often find the weight comes back. For those with binge-eating disorder, stopping the medication can also mean a return of binge episodes, compounding the regain.
Cardiovascular Effects Worth Knowing About
Because Vyvanse increases norepinephrine activity, it has a mild but measurable effect on your heart. A meta-analysis of over 2,600 adults found that stimulant medications raised resting heart rate by about 5.7 beats per minute and systolic blood pressure (the top number) by 1 to 5 points. Some studies also found diastolic pressure increases of up to 7 points. These shifts are small for most people, but they matter if you already have high blood pressure or heart concerns. Regular monitoring is standard practice while on the medication.
Vyvanse Is Not a Weight Loss Medication
Vyvanse is FDA-approved for two conditions: ADHD and moderate-to-severe binge-eating disorder. It is not approved for weight loss or obesity treatment. The FDA labeling states this explicitly. Prescribing it off-label purely for weight management is uncommon and comes with the full side effect profile of a stimulant, including potential for dependence, sleep disruption, increased heart rate, and mood changes.
If you’re taking Vyvanse for ADHD or binge-eating disorder and noticing weight loss, that’s a known and expected side effect. If you’re losing more than feels healthy, or if you’re struggling to eat enough, that’s worth raising with whoever prescribed it. Dose adjustments, meal timing strategies, and calorie-dense foods can all help manage excessive appetite loss while staying on the medication.